Tag: patient access
-
Is New Zealand entering a more collaborative era in medicines policy?
Some New Zealand patients can wait years longer for access to publicly funded new medicines than patients in comparable OECD countries. For people living with serious conditions such as cancer, rare diseases and autoimmune disorders, those delays can mean treatments available overseas are simply not yet options here. That gap has long been accepted as…